Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. EPS (Diluted) for the year ending December 31, 2023: USD 1.47

Pharmanutra S.p.A. EPS (Diluted) is USD 1.47 for the year ending December 31, 2023, a -12.05% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Pharmanutra S.p.A. EPS (Diluted) for the year ending December 31, 2022 was USD 1.67, a 3.26% change year over year.
  • Pharmanutra S.p.A. EPS (Diluted) for the year ending December 31, 2021 was USD 1.62, a -8.74% change year over year.
  • Pharmanutra S.p.A. EPS (Diluted) for the year ending December 31, 2020 was USD 1.77, a 81.42% change year over year.
  • Pharmanutra S.p.A. EPS (Diluted) for the year ending December 31, 2019 was USD 0.98, a -3.06% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO Mr. Andrea Lacorte
IPO Date July 18, 2017
Location Italy
Headquarters Via delle Lenze 216/B
Employees 112
Sector Health Care
Industries
Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Similar companies

ELN.MI

EL.En. S.p.A.

USD 11.22

0.24%

TNXT.MI

Tinexta S.p.A.

USD 7.98

1.79%

DGV.MI

Digital Value S.p.A.

USD 23.60

4.01%

SES.MI

SeSa S.p.A.

USD 59.41

-1.86%

WIIT.MI

Wiit S.p.A.

USD 19.07

-1.00%

StockViz Staff

January 15, 2025

Any question? Send us an email